Press release
Glycomic Therapeutics Market Size, Share Analysis, Trends, Growth And Forecast To 2032
Glycomic Therapeutics Global Market
The Business Research Company's Glycomic Therapeutics Global Market Report 2023 identifies increase in the prevalence of diabetes as the major driver for the Glycomic Therapeutics market's growth in the forecast period. Diabetes is a chronic medical condition that affects the body's ability to regulate blood sugar (glucose) levels. In diabetes, alterations in glycans have been observed, which can contribute to insulin resistance and other metabolic abnormalities. Specific glycan patterns serve as biomarkers for diagnosing diabetes, predicting its progression, and monitoring treatment responses.
The global glycomic therapeutics market size is expected to grow from $121.85 billion in 2022 to $141.31 billion in 2023 at a compound annual growth rate (CAGR) of 16.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of glycomic therapeutics market is expected to reach $255.71 billion in 2027 at a CAGR of 16.0%.
Download Free Sample Of Glycomic Therapeutics Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=11894&type=smp
Major competitors in the Glycomic Therapeutics market are F Hoffmann-La Roche Ltd., Bayer AG, Sanofi SA, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Merck KGaA, ICON plc, Agilent Technologies Inc., AMS Bio, Shimadzu Corporation, Waters Corporation, Bruker Corporation.
A key trend in the Glycomic Therapeutics market includes Product innovation. Major companies operating in the glycomic therapeutics sector are focused on developing new technological and innovative solutions to strengthen their position in the market.
Read More On The Global Glycomic Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/glycomic-therapeutics-global-market-report
The Glycomic Therapeutics market is segmented -
1) By Class: Isolated, Synthetic
2) By Structures: Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures
3) By Mode Of Action: Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1, 2 And 3, Beta And Gamma Interferons, Other Mode Of Action
4) By Indications: Thrombosis And Chemoprophylaxis, Anemia, Anti-Adhesive And Anti-Inflammatory, Cataracts, Gaucher's Disease, Mps-1 And IV, Cancer, Alzheimer's Disease, Influenza Type A And B, Other Indications
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Glycomic Therapeutics market.
The Business Research Company's "Global Glycomic Therapeutics Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Glycomic Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11894
The Table Of Content For The Glycomic Therapeutics Market Include:
1. Executive Summary
2. Glycomic Therapeutics Market Characteristics
3. Glycomic Therapeutics Market Trends And Strategies
4. Glycomic Therapeutics Market - Macro Economic Scenario
5. Glycomic Therapeutics Market Size And Growth
……
27. Glycomic Therapeutics Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Glycomic Therapeutics Market
29. Glycomic Therapeutics Market Future Outlook And Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glycomic Therapeutics Market Size, Share Analysis, Trends, Growth And Forecast To 2032 here
News-ID: 3215994 • Views: …
More Releases from The Business research company
Rising Cancer Prevalence Fuels Growth Of Antiemetics And Antinauseants Market: S …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Antiemetics And Antinauseants Market Size By 2025?
The market for antiemetics and antinauseants has been progressively increasing in size over the past few years. It is projected to escalate from $8.19 billion in 2024 to approximately $8.48 billion in 2025, exhibiting a compound annual growth…
Increasing Cancer Epidemic Driving Growth In The Oligonucleotide Therapy Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Oligonucleotide Therapy Market Size Growth Forecast: What to Expect by 2025?
The market size for oligonucleotide therapy has been swiftly expanding in the past few years. Projected growth is from $5.61 billion in 2024 to $6.2 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%. The…
Anesthetics Market Landscape to 2034: Key Forces Shaping the Next Decade of Grow …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Anesthetics Market Size By 2025?
In the past few years, there has been a steady increase in the size of the anesthetics market. It is projected to expand from $9.73 billion in 2024 to $10.16 billion in 2025, with a compound annual growth rate (CAGR)…
Future of the Meningococcal Vaccines Market: Trends, Innovations, and Key Foreca …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Meningococcal Vaccines Market Size Growth Forecast: What to Expect by 2025?
In recent times, the dimension of the meningococcal vaccines market has seen robust expansion. It is projected to swell from $3.89 billion in 2024 to $4.26 billion in 2025, marking a compound annual growth rate (CAGR) of 9.3%.…
More Releases for Glycomic
Rising Diabetes Prevalence Fuels Growth In The Glycomic Therapeutics Market: A S …
The Glycomic Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Glycomic Therapeutics Market Size and Projected Growth Rate?
In recent times, the market size for glycomic therapeutics has experienced swift expansion. It is projected to escalate from $164.71 billion in 2024 to…
Primary Catalyst Driving Glycomic Therapeutics Market Evolution in 2025: Rising …
What market dynamics are playing a key role in accelerating the growth of the glycomic therapeutics market?
The anticipated rise in diabetes cases is predicted to propel the expansion of the glycomic therapeutics market. Diabetes, a long-lasting health condition, impairs the body's capacity to regulate blood sugar or glucose levels. Notably, changes in glycans have been identified in diabetes, which possibly contribute to insulin resistance and additional metabolic irregularities. Particular patterns…
Glycomic Therapeutics Market Analysis till 2028 - Scope of The Report
The global glycomic therapeutics market is expected to grow from US$ 99,021.46 million in 2021 to US$ 257,578.79 million in 2028; it is estimated to grow with a CAGR of 15.8% from 2022 to 2028. The report highlights prevailing trends and factors driving the market growth.
The demand for glycomic therapeutics is attributed to a wide application of glycan-based drugs followed by the development of new treatment processes, increasing research and…
Glycomic Therapeutics Market Insights, Demand, and Forecast to 2033
"The new report published by The Business Research Company, titled Glycomic Therapeutics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the glycomic therapeutics market size has grown rapidly in recent years. It will grow from $141.31 billion in…
Glycomic Therapeutics Market: Advancements, Opportunities, and Growth Potential
Market Overview:
Glycomic therapeutics involves the development and utilization of glycan-based drugs or therapies to target specific molecular interactions and pathways in the human body. Glycans play critical roles in cell communication, immune responses, and disease progression, making them attractive targets for therapeutic interventions. The market encompasses various applications, including cancer therapeutics, infectious disease therapeutics, and personalized medicine.
Market Size and Growth:
The Glycomic Therapeutics Market is experiencing significant growth, driven…
Glycomic Therapeutics Market Comprehensive Analysis and Future Estimations by 20 …
The global Glycomic Therapeutics Market is expected to grow from US$ 99,021.46 million in 2021 to US$ 257,578.79 million in 2028; it is estimated to grow with a CAGR of 15.8% from 2022 to 2028.
The report highlights prevailing trends and factors driving the market growth.
The demand for glycomic therapeutics is attributed to a wide application of glycan-based drugs followed by the development of new treatment processes, increasing research and development…
